Screening Marine Microbial Metabolites as Promising Inhibitors of Borrelia garinii: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment

Table 1

Pan-proteome statistics for 37 B. garinii strains studied.

Genome no.	Organism name	No. of core genes	No. of accessory genes	No. of unique genes	No. of exclusively absent genes
1	IPT105	37	1169	14	0
2	IPT107	37	444	30	43
3	IPT108	37	1138	22	0
4	IPT113	37	1046	43	0
5	IPT114	37	1051	26	1
6	IPT115	37	1043	41	2
7	IPT117	37	774	34	14
8	IPT120	37	1148	14	0
9	IPT124	37	1181	22	0
10	IPT126	37	926	44	6
11	IPT128	37	1086	69	1
12	IPT129	37	984	46	2
13	IPT130	37	1067	25	0
14	IPT131	37	1139	36	0
15	BgVir	37	765	4	0
16	IPT74	37	1156	55	0
17	IPT75	37	1145	27	0
18	IPT76	37	1168	24	0
19	IPT86	37	1001	52	1
20	IPT88	37	1179	32	1
21	IPT89	37	1171	36	0
22	IPT90	37	1014	48	1
23	IPT91	37	1079	32	3
24	IPT94	37	1142	34	0
25	IPT96	37	1186	7	0
26	IPT98	37	947	49	3
27	IPT99	37	1131	17	3
28	IPT101	37	872	42	15
29	IPT104	37	1160	21	0
30	IPT133	37	1112	20	0
31	IPT134	37	1210	17	0
32	IPT136	37	1053	44	1
33	IPT139	37	1089	26	0
34	IPT140	37	1084	42	1
35	PBi	37	857	19	0
36	PBr	37	1114	8	0
37	SZ	37	769	1	0